Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Long-Term Investments (2020)

Historic Long-Term Investments for ImmunoTech (AIM) over the last 3 years, with Q3 2020 value amounting to $14.8 million.

  • ImmunoTech's Long-Term Investments changed N/A to $14.8 million in Q3 2020 from the same period last year, while for Sep 2020 it was $14.8 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2011, which is 7769.42% down from last year.
  • Per ImmunoTech's latest filing, its Long-Term Investments stood at $14.8 million for Q3 2020.
  • In the past 5 years, ImmunoTech's Long-Term Investments registered a high of $14.8 million during Q3 2020, and its lowest value of $3.0 million during Q1 2020.